Grok Pulse Oct 23, 2026 · 2 min read

Video explainer: OpenAI just knocked $150B off its own price tag. And one person close to the deal called the investor reaction "a bit of a thud."

OpenAI just knocked $150B off its own price tag. And one person close to the deal called the investor reaction "a bit of a thud."

Per @CNBC @OpenAI is close to raising up to $30B at a $1.25T valuation, led by UAE investors and Coatue. Signatures are due by the end of next week.

Earlier this month it pitched $1.4T. Some investors pushed back. "There has been zero clamouring," one person told the @FT.

It's still almost 50% above the $852B valuation from March. At ~$50B in annualized revenue that's roughly 25x sales. And @AnthropicAI is lining up its own IPO next month at up to ~$2T.

I think this pushback is healthy because a trillion dollar valuation should have to earn it. When even @sama's OpenAI has to take a haircut investors are finally doing the math on AI.

Would you buy OpenAI at $1.25T?


The quick version in two pics: $1.4T pitch down to $1.25T, still ~25x sales and way above March. Bargain or still too rich?

Sources: CNBC scoop by Kate Rooney and Ashley Capoot, published Thu Oct 22 2026 4:15pm ET 20:15 UTC · Earliest X posts: @Techmeme 4:24pm ET , @Kr00ney scoop post 4:58pm ET 43.6k impressions · Earliest X posts: @Techmeme 4:24pm ET , @Kr00ney scoop post 4:58pm ET 43.6k impressions · Up to $30B at $1.25T pre money, led by UAE investors and Coatue, an "opportunistic" bridge ahead of a potential IPO: CNB · Up to $30B at $1.25T pre money, led by UAE investors and Coatue, an "opportunistic" bridge ahead of a potential IPO: CNB · Target cut by $150B from the $1.4T pitched earlier in October after investor pushback: Bloomberg via Business Standard ,

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →